Article
NCAPG Is a Promising Therapeutic Target Across Different Tumor Types
2 Apr 2020
Abstract excerpt
BACKGROUND: With the advent of CRISPR-Cas9 genome editing tool in gene therapy, identification of aberrantly expressed genes is of great value across various cancer types. Since a large number of patients may benefit from molecular targeted gene therapy. The purpose of this study was to identify aberrantly expressed genes across various cancer types, analyze prospective mechanisms and their correlation with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
